Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 923093 STAMFORD, CT

Position in BMRN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
13 quarters on record

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Derivatives in BMRN

reported options exposure · as of Jun 30, 2026
CallValue
$526,424
CallShares
9,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in BMRN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $526,424 9,200
2026-03-31 $305,046 5,400
2026-03-31 $531,006 9,400
2025-12-31 $6,271,231 105,523
2025-12-31 $1,782,900 30,000
2025-12-31 $1,586,781 26,700
2025-09-30 $2,854,232 52,700
2025-09-30 $2,648,424 48,900
2025-06-30 $2,732,009 49,700
2025-06-30 $1,671,088 30,400
2025-06-30 $3,174,517 57,750
2025-03-31 $749,314 10,600
2025-03-31 $5,306,415 75,066
2025-03-31 $1,611,732 22,800
2024-12-31 $1,367,184 20,800
2024-12-31 $926,793 14,100
2024-12-31 $6,554,924 99,725
2024-09-30 $6,520,662 92,768
2024-09-30 $913,770 13,000
2024-09-30 $358,479 5,100
2022-12-31 $4,043,975 39,076
2022-03-31 $614,949 7,976
2021-06-30 $234,800 2,814
2020-12-31 $1,507,128 17,187
2020-09-30 $290,549 3,819